Matthias Kretschmer, PhDSenior Director Analytical Sciences at Alnylam Pharmaceuticals
Senior Director of Analytical Sciences at Alnylam Pharmaceuticals, responsible since 2008 for development of analytical methods and testing of siRNA pharmaceuticals. Prior to Alnylam, lead the Product Quality Management and QC Chemistry groups at Biogen from 2002 – 2008. From 1997 to 2002 responsible for the development of release test methods for Tysabri. Before Biogen, Scientist in Product Biochemistry at AutoImmune, characterization of myelin
proteins. PhD in chemistry from University of Leipzig. Discovered yeast PFK2 / FBPase 2 genes during postdoctoral training in yeast genetics and enzymology at Harvard Med. School. Throughout career developed software for analytical and quality testing purposes.